Paper · 2026 · Open access
Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review
Zenodo (CERN European Organization for Nuclear Research) · Published 3 April 2026 · DOI 10.5281/zenodo.19411008
In brief
“Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review” is a 2026 paper by Jadhav Kshitija R.*, Milke Umed. R., Sheikh Sameer. S., published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
Retention mechanisms in biological systems help transport essential organic and inorganic substances into the body and maintain their bioavailability. One of the major reasons for poor bioavailability of drugs is inadequate solubility or permeability. Among these, poor aqueous solubility is the most common problem faced by many drug molecules. With the continuous advancement in pharmaceutical and chemical sciences, the need for developing new drug delivery technologies has increased, and the selection of technology depends on the specific properties of each drug. Many drugs exhibit very low water solubility, which limits their dissolution rate in the gastrointestinal tract. Since drug dissolution is a rate-limiting step for absorption, poor solubility directly affects therapeutic effectiveness. The oral route is the most convenient and widely preferred method for drug administration because of its ease of use and patient compliance. According to the Biopharmaceutics Classification System (BCS), drugs are divided into four classes based on solubility and permeability. Solubility-related challenges are mainly observed in BCS Class II and Class IV drugs. To improve the solubility and bioavailability of poorly soluble drugs, various techniques and strategies are applied. These methods include physical and chemical modification of drug substances, particle size reduction, and the use of solubility enhancement technologies. The selection of an appropriate solubility enhancement method depends on several factors such as drug properties, absorption site, and desired dosage form characteristics.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
S., J. K. R. M. U. R. S. S. (2026). Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19411008
MLA 9
S., Jadhav Kshitija R.*, Milke Umed. R., Sheikh Sameer. “Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.19411008.
Chicago
S., Jadhav Kshitija R.*, Milke Umed. R., Sheikh Sameer. 2026. “Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19411008.
Harvard
S., J. K. R. M. U. R. S. S. (2026) ‘Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.19411008.
IEEE
J. K. R. M. U. R. S. S. S., “Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.19411008.
BibTeX
@article{s2026approaches,
title = {{Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review}},
author = {S., Jadhav Kshitija R.*, Milke Umed. R., Sheikh Sameer.},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.19411008},
url = {https://doi.org/10.5281/zenodo.19411008}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- solubility enhancement
- poorly water-soluble drugs
- bioavailability
- drug dissolution
- oral drug delivery
- Biopharmaceutics Classification System
- particle size reduction
- drug modification
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
S., J. K. R. M. U. R. S. S. (2026). Approaches for Solubility Enhancement in Pharmaceutical Drug Development: A Comprehensive Review. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19411008
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).
Who wrote this paper?
Jadhav Kshitija R.*, Milke Umed. R., Sheikh Sameer. S..
What is the DOI of this paper?
10.5281/zenodo.19411008. The permanent link is https://doi.org/10.5281/zenodo.19411008.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.